Qiankun Wang obtained his Ph.D. from Wuhan University, focusing on the HIV/AIDS gene therapy. He next conducted postdoctoral training at Washington University School of Medicine, where he studied the role of inflammasome in HIV pathogenesis and cure using the humanized mouse model. He joined the Shenzhen Bay laboratory as a Principal Investigator in 2024.

Qiankun Wang's major research areas and discoveries are as follows:

1. Molecular mechanisms of HIV pathogenesis

CD4+ T cell loss during chronic HIV-1 infection is a hallmark of AIDS progression. The underlying mechanism of CD4+ T cell depletion during HIV-1 infection is not well understood. We recently identified that the CARD8 inflammasome drives bystander CD4+ T cell depletion and disease progression by rapidly sensing HIV particles. Furthermore, we discovered the loss-of-function mutations in CARD8 from African small non-human primates, which may explain the peculiarly non-pathogenic nature of SIV infections.

2. Novel immunological strategies to eliminate HIV-infected cells

HIV-1 latent reservoir is the major barrier to an HIV cure. We recently reported that targeting CARD8 inflammasome may be a promising strategy to eliminate residual HIV-1-infected cells. We found premature activation of intracellular HIV-1 protease by non-nucleoside reverse transcriptase inhibitor (NNRTI) triggers CARD8 sensing and pyroptosis of HIV-infected macrophages and CD4+ T cells.